Over multiple generations, small nematode worms began preferring microplastic-contaminated food over cleaner options, which could have consequences for ecosystem health
Category: health – Page 30
Allergies linked to lower lung cancer risk, new study finds
Relevant data, including study design, geographic region, participant characteristics, and results, were extracted from the selected studies. The Newcastle-Ottawa Scale was used to assess the quality of studies and rate them as having low, moderate, or high quality.
The associations between allergic diseases and the risk of lung cancer were assessed using random and fixed effects models. Heterogeneity was evaluated using the I-squared statistic and chi-squared test. Sensitivity analyses indicated that no single study significantly influenced the overall effect size, supporting the robustness of the findings.
The search protocol yielded 226 studies. Following deduplication, title/abstract screening, and full-text reviews, 10 studies were selected for the meta-analysis. Of these, eight were case-control studies and two were cohort studies, cumulatively encompassing over 3.8 million participants.
Running injuries often strike suddenly, not gradually: Study challenges understanding of overuse injuries
A new study from Aarhus University turns our understanding of how running injuries occur upside down. The research project, which is the largest of its kind ever conducted, shows that running-related overuse injuries do not develop gradually over time, as previously assumed, but rather suddenly—often during a single training session. The research is published in the British Journal of Sports Medicine.
“Our study marks a paradigm shift in understanding the causes of running-related overuse injuries. We previously believed that injuries develop gradually over time, but it turns out that many injuries occur because runners make training errors in a single training session,” explains Associate Professor Rasmus Ø. Nielsen from the Department of Public Health at Aarhus University, who is the lead author of the study.
The study followed 5,205 runners from 87 countries over 18 months and shows that injury risk increases exponentially when runners increase their distance in a single training session compared to their longest run in the past 30 days. The longer the run becomes, the higher the injury risk.
Inhaled farm dust alters gut bacteria and weakens intestinal barrier in mice
Inhaling agricultural dust may pose significant risks to gut health for workers in animal agriculture, a University of California, Riverside, study has found.
Led by Declan McCole, a professor of biomedical sciences in the UCR School of Medicine, the study expands on prior findings that hog farm dust causes airway inflammation. The researchers now report in the Journal of Applied Toxicology that inhaling this dust also alters the gut microbiome and impairs intestinal function, including increased “leaky gut” or intestinal permeability. Leaky gut is associated with a range of chronic diseases, including inflammatory bowel disease, celiac disease, and type 1 diabetes.
“Exposure to swine farm dust, which contains high levels of bacteria and endotoxins, caused both airway inflammation and increased passage of gut bacterial products into the bloodstream in our mouse models,” said Meli’sa Crawford, a former postdoctoral researcher in McCole’s lab and the paper’s first author. “But what’s especially striking is the impact we observed on the gut microbiome and metabolism.”
Stevia leaf extract has potential as anticancer treatment, researchers find
Stevia may provide more benefits than as a zero-calorie sugar substitute. When fermented with bacteria isolated from banana leaves, stevia extract kills off pancreatic cancer cells but doesn’t harm healthy kidney cells, according to a research team at Hiroshima University.
The researchers published their findings on April 28 in the International Journal of Molecular Sciences.
“Globally, the incidence and mortality rates of pancreatic cancer continue to rise, with a five-year survival rate of less than 10%,” said co-author Narandalai Danshiitsoodol, associate professor in Department of Probiotic Science for Preventive Medicine, Graduate School of Biomedical and Health Sciences.
Tsinghua University holds Tsinghua AI Agent Hospital Inauguration and 2025 Tsinghua Medicine Townhall Meeting-Tsinghua University
On the morning of April 26, Tsinghua University held an inauguration ceremony for Tsinghua AI Agent Hospital and the 2025 Tsinghua Medicine Townhall Meeting at the Main Building Reception Hall. Tsinghua President Li Luming and Vice President Wang Hongwei attended the event.
President Li Luming reviewed the progress of Tsinghua University’s medical programs over the past year, emphasizing the University’s strong commitment to the development of medical disciplines. He highlighted Tsinghua’s strength in fundamental research in Artificial intelligence, which has already led to a series of high-level innovations at the intersection of AI and medicine. The establishment of the Tsinghua AI Agent Hospital represents a new initiative by Tsinghua to leverage its strengths in science and engineering to empower the advancement of medicine.
President Li encouraged Tsinghua Medicine to remain committed to fostering virtue and talent, cultivating a new generation of medical innovators with both a strong medical foundation and AI literacy. He also called for deeper integration across disciplines, particularly between engineering and medicine, as well as closer ties between clinical practice and technology. Finally, he urged Tsinghua Medicine to align its work with cutting-edge global trends and national strategic needs, driving medical advancement and contributing to the protection of public health.
CRISPR uncovers gene that supercharges vitamin D—and stops tumors in their tracks
A gene called SDR42E1 has been identified as a key player in how our bodies absorb and process vitamin D. Researchers found that disabling this gene in colorectal cancer cells not only crippled their survival but also disrupted thousands of other genes tied to cancer and metabolism. This opens the door to highly targeted cancer therapies—by either cutting off vitamin D supply to tumors or enhancing the gene’s activity to boost health. The findings hint at vast possibilities in treating diseases influenced by vitamin D, though long-term impacts remain uncertain.
Guselkumab demonstrates superior efficacy in clinical trials, offering new hope to Crohn’s disease patients
In a major advance for patients with Crohn’s disease, a new study led by researchers at Mount Sinai Health System found that guselkumab, a medication with a mechanism of action that is new to inflammatory bowel disease (IBD) treatment, outperformed an established standard of care in promoting intestinal healing and symptom relief.
These findings from two pivotal Phase III trials known as GALAXI 2 and 3, published in The Lancet, provided the basis for the recent Food and Drug Administration approval of guselkumab (brand name Tremfya) for the treatment of moderately to severely active Crohn’s disease.
Crohn’s disease affects roughly 780,000 people in the United States and often requires a lifetime of management. Despite numerous available biologic medications, many patients fail to achieve sustained remission. Guselkumab blocks the interleukin-23 (IL-23) pathway, a key driver of chronic intestinal inflammation.
Gene essential for vitamin D absorption could help unlock treatments for cancer and autoimmune diseases
Vitamin D is not only an essential nutrient, but also the precursor of the hormone calcitriol, indispensable for health. It regulates the uptake of phosphate and calcium necessary for bones by the intestines, as well as cell growth and the proper function of muscles, nerve cells, and the immune system.
Now, researchers have shown for the first time in Frontiers in Endocrinology that a particular gene called SDR42E1 is crucial for taking up vitamin D from the gut and further metabolizing it—a discovery with many possible applications in precision medicine, including cancer therapy.
“Here we show that blocking or inhibiting SDR42E1 may selectively stop the growth of cancer cells,” said Dr. Georges Nemer, a professor and associate dean for research at the University College of Health and Life Sciences at Hamad Bin Khalifa University in Qatar, and the study’s corresponding author.
Landmark study investigates potential of Ambroxol, a cough medicine, to slow Parkinson’s-related dementia
LONDON, Ont. – Dementia poses a major health challenge with no safe, affordable treatments to slow its progression.
Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph’s Health Care London, are investigating whether Ambroxol — a cough medicine used safely for decades in Europe — can slow dementia in people with Parkinson’s disease.
Published today in the prestigious JAMA Neurology, this 12-month clinical trial involving 55 participants with Parkinson’s disease dementia (PDD) monitored memory, psychiatric symptoms and GFAP, a blood marker linked to brain damage.
Parkinson’s disease dementia causes memory loss, confusion, hallucinations and mood changes. About half of those diagnosed with Parkinson’s develop dementia within 10 years, profoundly affecting patients, families and the health care system.